Public High Schools - Student Transcripts - Traumatic Loss Notation
Impact
This legislation is expected to significantly impact state public health laws by creating a more inclusive framework for the donation and distribution of prescription and over-the-counter medications. Eligible recipients include individuals who are uninsured, underinsured, or enrolled in public health benefit programs, thereby expanding access to necessary medical treatments within the community. The bill also outlines procedures for ensuring compliance with state and federal laws regarding drug storage, distribution, and dispensing, alongside reinforcing the standards for donated medications.
Summary
House Bill 1310, titled 'Prescription Drug Repository Program - Revisions', seeks to enhance the existing Prescription Drug Repository Program in the state of Maryland. The bill allows pharmacy entities licensed in other states to be designated as repositories within the program. It expands the types of medications eligible for donation, specifically including over-the-counter drugs, and facilitates the procedural requirements for accepting these medications, aiming to increase the availability of medical supplies for needy individuals.
Sentiment
The sentiment surrounding HB 1310 appears to be positive with a focus on facilitating healthcare access and improving the current repository program. Supporters argue that the bill will address important public health needs by ensuring that more medications are available to those who need them, potentially reducing healthcare costs for individuals. However, the inclusion of out-of-state pharmacies raises some concerns regarding the regulation and safety of medications dispensed by these external entities, which could be a point of contention among medical professionals and consumer advocacy groups.
Contention
Notable points of contention arise from the bill's provision that allows out-of-state pharmacies to participate in the program as repositories. Critics may challenge the adequacy of oversight for these pharmacies and whether they will meet the same safety and quality standards that in-state pharmacies are required to uphold. Additionally, the bill's provisions for liability immunity for those involved in the donation and dispensing process may lead to ongoing debates about accountability, especially in cases where patients may suffer adverse effects from donated medications.
Further providing for title and short title of act, for definitions, for establishment, for restocking and dispensing of cancer drugs, for storage, distribution and fees and for immunity; providing for annual report and for list of approved participating pharmacies; further providing for regulations; and imposing duties on the State Board of Pharmacy.
A bill for an act relating to the provision of accessible prescription-related measures for persons who are blind, have a visual impairment, or other print disability. (Formerly HF 2033.) Effective date: 07/01/2026
A bill for an act relating to the provision of accessible prescription-related measures for persons who are blind, have a visual impairment, or other print disability.(See HF 2585.)